10th BSMA Conference – Foster City, CA 2017


October 12, 2017

Crowne Plaza Hotel, Foster City, California

For BSMA hotel rates & reservation, please click on hotel name above.
For directions, click here =>  Directions

“Driving Innovation and Technology
in the Bio-pharma Supply Chain”

Enjoy Scenes from the Inaugural Conference at Boston, MA (April 26, 2017)

8:30 am – 7:00 pm

Breakfast, Network Breaks, Lunch and Cocktail
will be served

General Event Schedule

BSMA Registration  – 7:30 AM

Plenary Sessions

Track Sessions

Keynote Address

Award Ceremony & Networking Cocktail Reception – 5:30-7:00pm


Welcome Address:  “Ten Years of Innovation & Technology: The Last and the Next!”
Speaker: Devendra Mishra, Executive Director & Co-Founder, BSMA

“Building a Real-Time Visibility Platform for Supply Chains: Innovation in Progress.”  Real time visibility in the supply chain is a strategic area of innovation at Genentech. The presentation will address the challenges and triumphs involved in assessing, selecting, and installing an “extreme visibility” platform over the last year. Our goal is to use this platform to “know what we don’t know,” understanding the real-time movements of our goods, have up-to-the-minute information of global events that could impact our supply chain, and provide this information to groups across the corporation. Insights will be provided in terms of problem articulation, requirements analysis, system solution selection, change management and cultural evolution.
Speaker:  Lisa Hammann, Vice President and Region Head, Supply Chain, North America, Genentech/Roche

KEYNOTE ADDRESS: “Pioneering the Development of the Supply Chain for Immuno-therapy Drugs: The Brave New World”   The challenges of developing innovative products that harness a patient’s own immune system to target and kill cancer cells is a paradigm of cancer treatment for the 21st century. The supply chain for such products is personalized, rendering its design, development and execution to be unprecedented. The establishment of processes for manufacturing and logistics, with real time controls, is a pioneering endeavor. Insights will also be provided of early clinical studies in patients who were treated with engineered T cells have produced dramatic results thus far, up to and including complete remission of cancer in some patients who have aggressive disease and have not responded to other therapies.
Keynote Speaker: Tim Moore, Executive Vice President, Technical Operations, Kite Pharma

“Supply Chain Transformation: Improving the Customer Experience for Competitiveness”:  Illumina is known for advancing health-care breakthroughs with the world’s leading genomic analysis products. Over the past two years, illumina has increased its focus on improving the customer experience through a customer-centric supply chain vision and strategy. This presentation will share some of Illumina’s segmentation and customer partnership strategies and results in the areas of service, launches, and cost savings.
Speaker:  Kevin Pegels, Vice President, Global Supply Chain, Illumina

“President Trump’s Tax and Trade Policies: Impact on Supply Chain and Business Strategy”:  Presentation will address how pharmaceutical and life sciences companies should waste no time in evaluating how different tax provisions would affect their business operations. The Trump administration also has begun proposing changes to trade policy. Pharma and life sciences companies should model how these proposed changes could affect manufacturing and supply chains, locations of intellectual property (IP) holdings, unremitted earnings held overseas and planned capital expenditures.
Speakers:  Jennifer Parkhurst,  Principal, Pharmaceutical & Life Sciences Advisory, PwC; Ben Proce, Vice Partner, Pharma and Life Sciences Tax Practice, PwC

EU and US Regulatory and Political Realities: Overcoming Obstacles of Supply Chain”: SMEs from both sides of the Pacific will address the regulatory challenges and potential economic realities of “Brexit” and “Making America Great Again” in terms of historical collaboration in drug development and delivery to markets. Insights will be shared in meeting challenges of clinical trials, temperature-controlled distribution and serialization. Leveraging Europe which also serves as a gateway to drug and vaccine delivery to the Mid-East and Africa, which are constrained by limited infrastructure, will be discussed. Practical suggestions for small and mid-sized companies aspiring to enter the EU market will be presented. 
PANELISTS:  Franck Toussaint, Managing Director, Biolog Europe; Laurent Foetisch, Managing Director, Supply Chain Operations SA;  Horacio Enriquez, Global Supplier Quality, Compliance, & Business Analytics Manager, Bio-Rad Laboratories; Moderator: Dave Malenfant, Executive Vice President, Industry Liaison and Talent Development, BSMA

“Building Global Operations Ecosystems with Blockchains”:  The way companies approach their information technology has remained largely unchanged for more than 50 years: internally focused with limited links to the outside world.  ERP and supply chain management systems are mostly about managing internal processes.  During this same time period, however, the world has moved on – from company-centered hierarchies to broad distributed operations networks.  In blockchain technology, we finally have the foundation on which to build ecosystem-wide management infrastructure and then optimize operations globally.  
Speaker:  TBA


PANEL: “Industry 360° – Taking a Quantum Leap in Rewiring the Biotech Supply Chain”:  Senior SCM executives of the bio-pharma industry will address the challenges of exponentially enhancing the delivery of patient care in the global market place with formidable governmental regulations through processes, systems and technology. What game changing initiatives can the industry engage in the areas of supplier relationships, contract manufacturing and clinical trials management, commercialization, manufacturing QA, temperature-controlled distribution and human resource development. The deployment of disruptive technologies will also be discussed to achieve growth and profitability.
PANELISTS:  Robert Bottome, , ‎Sr. Director, Global Supply Chain, BioMarinSom Chattopadhyay, Vice Vice President, Global Supply Chain, AmgenKevin Pegels, Vice President, Global Supply Chain USA, Illumina; Prashant Yadav, Strategy Leader-Supply Chain, Bill & Melinda Gates Foundation; MODERATOR: Devendra Mishra, , Executive Director, BSMA

“Enabling Technologies for Supply Chain Innovations” Information and Technology are revitalizing the supply chain of bio-pharma in terms of efficiency, agility, visibility and integrity while better sensing of demand. From clinical supply to drug delivery to patients, the emerging technologies of data analytics, serialization, environmental condition monitoring, real time demand sensing, artificial intelligence (AI), machine learning, PLM and Blockchain have game changing implications. Further, the Cloud in the digital supply chain is enabling realization of quantum leaps in maximizing drug development and delivery of patient care. SMEs will address the major problems faced by the industry and how solutions are being implemented to solve them.
Moderator: Todd Hein, Sr. Director – Medical Devices – IBU, , Oracle

“Economic Development of California: Our Call to Action for Biomedical and Bio-pharma!”: The mission of the development of a strong and diverse regional economy requires the partnership between the government, agencies and the business community. Leaders of the Municipal Government of Fremont, Managing Director of BIOCOM and the Program Director of the Biomedical Manufacturing Network will present their commitment to revitalization, retail recruitment, corporate retention, and small business development in California. 
SPEAKERS:  Rick Fultz, Chief Business Development Officer & Managing Director, Biocom Purchasing Group, BiocomKelly Kline, Chief Innovation Officer, City of FremontGregory Theyel, Program Director, Biomedical Manufcaturing Network


Sessions:  TBA




PANEL: “The Resurgence of Manufacturing in Biomedical and Bio-pharma Manufacturing: Overcoming Trials and Tribulations”  Manufacturing has proved to be a strategic asset in the biopharma and biomedical industries where product development, product design iterations after R&D, pilot and small to large scale manufacturing, and customer-driven product innovations, are extremely intertwined in a continuous improvement environment. Achieving responsiveness to product and process changes, agility in delivering innovations, protection of intellectual property, and reduction in time to market, will be addressed by an esteemed panel of stakeholders. The SMEs will also assess the management issues of how to establish manufacturing after the product has been designed and is likely to evolve to a steady-demand, mass-produced product where achieving economy becomes a competitive imperative. In the context of the product life cycle, from conception to becoming a mature product, the decisions to offshore or inshore will be analyzed. Lessons learned from successes and failures will also be examined.
PANELISTS: TBA; Moderator: Dr. Gregory Theyel, Program Director, Biomedical Manufacturing Network

Sessions:  TBA


 PANEL: Leveraging Trends in Logistics 2017- Empowering Strategic Partnering in Total Cost of Ownership(TCO) : Advances in logistics with IoT, Network and AI and Data Analytics will be discussed which have significant potential for deployment in daily business. In addition, leverage trends in Logistics 2017. empowering strategic partnering in Total Cost of Ownership(TCO), mode conversion, and data analytics will be highlighted for solutions.   
PANELISTS: TBA; Moderator: Joel Glende, Executive Officer, Paladin Logistics Consulting

Sessions:  TBA


 PANEL: “Integrating Planning, Packaging, Logistics to Maximize Effectiveness of Clinical Trials”: This panel will address how operations planning, packaging, information systems, business practices and collaboration will improve accountability and visibility in the supply chain linking clinical drug discovery, clinical operations and clinical supply with trials management and service providers.  Topics covered will include patient enrollment forecasting and real time updating, managing inventory with MRP, and performing drug accountability and reconciliation, including returns.   
PANELISTS: TBA; Moderator: Ravi Kiron, Head, BioPharma External Innovation, EMD Serono

Sessions:  TBA